Europe Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstruc

Europe Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)

The Europe non-invasive ventilation masks market is expected to reach US$ 735.24 million by 2028 from US$ 515.45 million in 2021. The market is estimated to grow at a CAGR of 5.2% from 2021 to 2028.

As an early option in infectious patients with severe acute respiratory syndrome (SARS), H1N1, and Tuberculosis (TB) infections, NIV can prevent or reverse respiratory failure and reduce complications when taken in units with well-trained staff. NIV with a face mask can help eliminate the need for endotracheal intubation and, therefore, reduce the mortality rate in patients with acute respiratory failure. Regarding the choice of interfaces, full-face masks should be preferred over nasal masks to theoretically prevent the potential spread of contaminated airborne particles through accidental air leaks through the mouth. Therefore, it is critical to choose the brand and size of mask that best fits the anatomy of the patient's facial contours while also allowing an adequate pressure level to be delivered to minimize inadvertent air leaks around the interface.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the non-invasive ventilation masks market. The Europe non-invasive ventilation masks market is expected to grow at a good CAGR during the forecast period.

Europe Non-Invasive Ventilation Masks Market Revenue and Forecast to 2028 (US$ Million)

Europe Non-Invasive Ventilation Masks Market Segmentation

By Product

Non-Invasive Ventilation Reusable Masks Non-Invasive Ventilation Disposable Masks By Application

Chronic Obstructive Pulmonary Diseases Respiratory Dysfunction Pneumonia Others By End User

Pediatric ICU Home Care Others By Country

Germany UK France Spain Italy Benelux Rest of Europe Companies Mentioned

Hamilton Medical Res Med Inc. Fisher & Paykel Healthcare Limited. Air Liquide Medical Systems Dragerwerk AG & Co. KGa A Intersurgical Ltd BMC Medical Co., Ltd De Vilbiss Healthcare LLC VYAIRE MEDICAL, INC. ARMSTRONG MEDICAL Koninklijke Philips N.V.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe non-invasive ventilation masks market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe non-invasive ventilation masks market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.